Human herpesvirus-6 (HHV-6), like other betaherpesviruses, shows cell fusion with wild-type strains, and this cellular spread is mediated by the glycoprotein gH/gL complex. Anti-fusion monoclonal antibodies (MAbs) specific for HHV-6 glycoprotein gH inhibit infection and prevent cellular spread by syncytia formation. Reactivity of these MAbs with gH deletion mutants suggests a conserved C-terminal fusion-associated domain. A conserved motif here has an N-glycosylation site and characteristics of a beta turn. Motif deletion abrogated MAb recognition while coexpression with glycoprotein gL restored this conformational epitope, indicating the importance of folding and not glycosylation at this site. Our previous studies showed gL binding to gH at an Nterminal domain specific for betaherpesviruses. To further examine the function of this N-terminal domain, a betaherpesvirus-specific motif was deleted. This mutant gH still bound gL, and was recognized by the anti-fusion MAbs ; however, recognition was now primarily in the immature form and reduced during processing to the mature form. A model is discussed whereby gL binding gH at the N-terminal domain acts to draw together the C-terminal extracellular domain and this interaction affects a functional conformation during glycoprotein maturation.
Introduction
Herpesviruses encode a number of glycoproteins that are present in the envelope of the virion and play an important role in virus infectivity, being required for virus entry into cells and exit from infected cells. The genes encoding glycoproteins gB, gH, gL and gM are notable in that they are present in the genomes of all mammalian herpesviruses subgroups, alpha, beta and gamma (Gompels et al., 1995) . The gH glycoproteins show amino acid sequence identity in the C-terminal region, which includes paired cysteine residues and a putative Nglycosylation motif. The N-terminal region is more divergent and identity is restricted to within subfamilies. In comparison, gL homologues share little sequence identity across subfamilies and have been identified as positional homologues (Liu et al., 1993 b ; Spaete et al., 1993 ; Yaswen et al., 1993) .
A large number of studies have provided evidence supporting a role for gH and gL in the membrane fusion events Author for correspondence : Ursula Gompels.
Fax j44 171 637 4314. e-mail ugompels!hgmp.mrc.ac.uk involved in herpesvirus entry and cell-cell spread. Monoclonal antibodies (MAbs) specific for gH homologues of different human herpesviruses have been described which neutralized infectious virus in the absence of complement (Cranage et al., 1988 ; Foa-Tomasi et al., 1991 b ; Fuller et al., 1989 ; Gompels & Minson, 1986 ; Montalvo & Grose, 1986 ; Okuno et al., 1990 ; Simpson et al., 1993) . The neutralizing activity of some anti-gH MAbs was ascribed to blockage of virus penetration (Foa-Tomasi et al., 1991 b ; Fuller et al., 1989) . A herpes simplex virus type 1 (HSV-1) mutant virus deleted for gH coding sequences was defective for entry, and infectivity was partially rescued by treatment with the fusogen polyethylene glycol (Forrester et al., 1992) . The formation of cytopathic effect was inhibited following incubation with anti-gH MAbs post-infection, indicating a role for gH virus spread in vitro (Foa-Tomasi et al., 1991 b ; Gompels & Minson, 1986 ; Gompels et al., 1991 ; Rodriguez et al., 1993) . Penetration and spread in the murine nervous system requires pseudorabies virus gH (Babic et al., 1996) . The C-terminal portion of the human herpesvirus-6 (HHV-6) and HSV-1 gH ectodomain and residues in the HSV-1 cytoplasmic tail have R. A. Anderson and U. A. Gompels R. A. Anderson and U. A. Gompels been reported to be required for fusion (Browne et al., 1996 ; Galdiero et al., 1997 ; Peng et al., 1998 ; Wilson et al., 1994) .
Antibody reagents specific for gL have been described that had an inhibitory effect on virus infectivity and cell fusion (Klupp et al., 1997 ; Novotny et al., 1996 ; Peng et al., 1998) . Like gH mutant viruses, gL deletion mutants were also defective for penetration in vitro (Klupp et al., 1997 ; Roop et al., 1993) . HSV-1 gL antibody reactivity was mapped to the C terminus, implying a role for this region in fusion (Novotny et al., 1996) .
Co-immunoprecipitation experiments have shown that gH and gL form a heteromeric glycoprotein complex (Forghani et al., 1994 ; Hutchinson et al., 1992 ; Kaye et al., 1992 ; Liu et al., 1993 b ; Yaswen et al., 1993) . Recent data using chemical crosslinkers confirmed the presence of gH\gL oligomers in purified HSV-1 virions (Handler et al., 1996) . The concept of the gH\gL complex as a functional unit is based on observations that epitope formation, processing and targeting to cellular and virion membranes are aberrant when a component of the glycoprotein complex is lacking, and in vitro fusion assays which demonstrate that both gH and gL are required for the induction of syncitium formation (Cranage et al., 1988 ; Dubin & Jiang, 1995 ; Duus et al., 1995 ; Gompels & Minson, 1986 Hutchinson et al., 1992 ; Klupp et al., 1997 ; Roberts et al., 1991 ; Roop et al., 1993 ; Spaete et al., 1993 ; Turner et al., 1998) . The gH\gL complex probably requires multiple protein-protein contacts for assembly, conformation, stability or function, and the molecular mechanisms involved are beginning to be elucidated. The requirement for intermolecular disulfide bridges was important for complex formation in betaherpesviruses human cytomegalovirus (HCMV) or HHV-6 (Anderson et al., 1996 ; Kaye et al., 1992 ; Spaete et al., 1993) , but not for association of gH and gL in alphaherpesviruses HSV-1, varicella-zoster virus (VZV) or bovine herpesvirus-1 (Duus & Grose, 1996 ; Duus et al., 1995 ; Hutchinson et al., 1992 ; van Drunen Littel-van den Hurk et al., 1996) . However, disruption of intramolecular disulfide bonds affected VZV gL properties associated with gH maturation and transport (Duus & Grose, 1996 ; Duus et al., 1995) , indicating that cysteine residues may be important for processes other than complex formation. Analysis of HSV antibody-resistant mutants provided the first evidence for interaction of gL with an N-terminal portion of the gH extracellular domain (Gompels et al., 1991) . Studies with the betaherpesviruses HHV-6 and HCMV showed gL binding at an N-terminal domain of gH which was subgroup-specific (Anderson et al., 1996) . Studies on HSV-1 gL show that the Nterminal 168 amino acids are sufficient for gH binding (Peng et al., 1998) , consistent with the observation that C-terminal amino acids of VZV gL were not required for interaction with gH (Duus et al., 1995) .
Additional components of the gH\gL complex have been described for the gamma-and betaherpesviruses Epstein-Barr virus (EBV) and HCMV, respectively. The EBV gH\gL complex was shown to include a third glycoprotein, called gp42, encoded by the BZLF2 ORF (Li et al., 1995) . gp42 appears to be necessary for infection of peripheral blood Blymphocytes but not cells of epithelial origin (Li et al., 1995) . The HCMV virion envelope contains the gCIII complex (Gretch et al., 1988) . Components of gCIII include gH, gL and a third high molecular mass protein recently identified as gO (UL74) (Huber & Compton, 1998 ; . The presence of comparable gene products in the gH\gL complex of other herpesviruses has not as yet been reported. Cellular or viral proteins may interact with constituents of the gH\gL complex and provide a substitute transport function (Duus et al., 1995 ; Spaete et al., 1993) . Heterologous complex formation has been demonstrated between gH and gL proteins from distinct herpesviruses (Anderson et al., 1996 ; Li et al., 1997 b) .
Little is known about the role of gL binding at the Nterminal domain of gH and its relationship to cell fusion mediated by this glycoprotein complex. As described above, our studies and those of other groups have shown that the conserved C-terminal domain is associated with mediating infection and fusogenic cell-cell spread. Here we have studied gH mutants with specific motif deletions in order to examine the relationship between gL binding at the N-terminal region with effects on the C-terminal putative ' fusion-associated ' domain. This paper investigates the role of conserved amino acid motifs in HHV-6 gH protein-protein interactions with gL and membrane fusion. This is relevant to fusion in Tlymphocytes, which this virus infects, causing syncytia formation followed by cell lysis (Gompels, 1998) . The results show evidence for N-and C-terminal interactions in gH and a role for gL binding gH (at the N-terminal region) in C-terminal fusion-associated conformation.
Methods
Cells and viruses. Vero cells were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 10 % foetal calf serum (Gibco BRL), 2 mM -glutamine, 1 % penicillin\streptomycin (ICN Biomedicals) ; replaced by Opti-MEM (Gibco BRL) for transfection of Vero cells. BHK cells were maintained in Glasgow modified Eagle medium with 10 % newborn calf serum, 10 % tryptose phosphate broth and antibiotics. Vaccinia virus vTF7-3 (ATCC ; VR-2513) was propogated in BHK cells (Mackett, 1995) and titrated on Vero cells.
Monoclonal antibodies. The gH MAbs were derived as described (Balachandran et al., 1989 ; Foa-Tomasi et al., 1991 b ; . MAbs 2E4, 5E7 and 1D3 were a gift from G. Campadelli-Fiume (University of Bologna, Italy) and 7A2 was provided by B. Chandran (University of Kansas, USA). MAb LP14 recognizes a 9 amino acid epitope from HSV-1 gD (Liu et al., 1993 b) and was donated by A. C. Minson (University of Cambridge, UK ; Minson et al., 1986) . 12CA5 was purchased from BAbCo, USA.
Plasmid constructs and site-directed mutagenesis. The generation of plasmid constructs encoding gH tagged with an exogenous LP14 epitope (pH6H4), epitope-tagged gH mutants (pH6H7, pH6H8 and pH6H10) and wild-type gL (pH6CH2) were as described (Anderson et al., 1996 ; Liu et al., 1993 b HHV-6 gH/gL and fusion conformation HHV-6 gH/gL and fusion conformation directed mutagenesis using the Kunkel method (Kunkel, 1985) . The primer 5h GGCTTTATAACAACAAAAAACGAC 3h was used in mutagenesis with template from pH6H4 or pH6H10 to produce pH6H11 and pH612, respectively. Mutants were identified by ABI Prism dye terminator cycle sequencing using a T7 promoter primer. The complete gH sequence was determined with multiple internal gH primers . Sequencing reactions were resolved on a Perkin Elmer ABI Prism 377 DNA sequencer. Sequence analysis and assembly of overlapping sequences was performed using Applied Biosystems Factura and AutoAssembler software.
Transient expression, radiolabelling proteins and immunoprecipitation. Vero cells were infected with 1 p.f.u. per cell vaccinia virus and incubated at 37 mC. Mixtures of Lipofectin (Gibco BRL) and plasmid DNA in Opti-MEM were added to infected cells and incubated for 4 h at 37 mC. Proteins were radiolabelled in DMEM minus methionine (Gibco BRL) with 15 µCi\ml [$&S]methionine ( 1000 Ci\mmol ; Amersham) for 13 h at 37 mC. Cells were washed in ice-cold PBS, and lysed in 0n5 ml RIPA buffer [50 mM Tris-HCl pH 7n5, 150 mM NaCl, 1 % sodium deoxycholate, 0n1 % SDS, 1 % Igepal CA-630 (Sigma)] on ice for 20 min. Cellular debris was pelleted by centrifugation at 13 000 g for 20 min. Lysates were precleared by addition of 25 µl of a 1 : 1 mix of RIPA buffer\protein A-Sepharose (Sigma) for 1 h at 4 mC followed by centrifugation at 13 000 g. The supernatant was removed, TCA precipitable counts estimated and samples adjusted to equivalent TCA counts with RIPA buffer. MAb (1 µl) was added to 0n5 ml samples and rotated at 4 mC for 18 h. Immune complexes were precipitated using protein A-Sepharose as above, washed five times with 1 ml RIPA buffer and 15 µl SDS loading buffer was added to the beads. For endoglycosidase H (Endo H) digestion of immunoprecipitation products, 50 mM Tris-HCl pH 7n4, 0n5 % SDS was added followed by incubation at 100 mC for 4 min. An equal volume of 0n1 M sodium citrate pH 5n3, 1 mM PMSF (Sigma) was added to the supernatant and an aliquot digested with 2 mU Endo H (ICN Biomedicals) at 37 mC for 18 h. 12 % (or 4-20 % gradient) precast mini-polyacrylamide gels were used (Novex). Samples were run in 25 mM Tris, 250 mM glycine, 0n1 % SDS at 20 mA constant current. Gels were fixed in 25 % isopropanol, 10 % acetic acid for 15 min at room temperature, incubated with Amplify (Amersham) for 15 min, then exposed to Hyperfilm (Amersham). Fig. 1 shows epitope-tagged gH (gH4) and recombinants derived from gH4 (gH5, -6, -7 and -8) used here, as described previously (Anderson et al., 1996 ; Liu et al., 1993 b) , together with the new gH4-derived mutant constructs gH11 and gH12 described below. Mutant gH6 (Q667) is a secreted form of gH recognized by gH MAbs, whereas gH5 (H645) loses reactivity to 1D3 and 5E7. These antibody reactivities and those of the other mutants are investigated further here in the presence or absence of gL. Mutant gH7 (D433) is deleted for part of the gH region that shows most conservation across herpesvirus subfamilies, as well as the transmembrane anchor and the cytoplasmic tail. The C-terminal region of the external domain includes four amino acids (NGS\TV) which are conserved in position and sequence in all gH homologues. This sequence fits the consensus for an N-linked glycosylation site, although it is not known if post-translational modification occurs here. Alternatively, these amino acids could be important for protein Fig. 1 . Schematic view of epitope-tagged gH wt (gH4) and derived mutants (gH5-12). The signal peptide and transmembrane region are indicated by open boxes at the N and C termini, respectively. The last amino acid in each protein is indicated according to the wt designation. β, β/γ and β/γ/α refer to regions conserved amongst gH homologues from the different subgroups (α, alpha ; β, beta ; and γ, gamma) determined by our previous HHV-6 sequence analyses (Anderson et al., 1996) . The Nterminal domain is subgroup-specific such that in comparisons amongst alphaherpesviruses this is alpha-specific as compared to the beta-specific domain shown and analysed here. F and N refer to the FNFY and NGSV conserved motifs and the triangles indicate their deletion. The N-terminal epitope tag is indicated by a star. The regions of gL binding and fusionassociated conformation are indicated as described in the text. conformation since they have characteristics of a beta turn. Mutant gH8 was constructed in order to delete the conserved amino acid motif, which is NGSV in HHV-6.
Results

Conserved domain and motif mutagenesis
We have defined a domain in the divergent N-terminal part of HHV-6 gH that was sufficient for gL binding in a transient assay system (Anderson et al., 1996) . This 230 amino acid portion is present in mutant gH10 and includes part of gH most closely conserved amongst betaherpesvirus-specific homologues. Multiple alignment of amino acid residues identified several conserved residues and highlighted a motif, FNF, at position 45-47 in the amino acid sequence within the minimal gL binding domain conserved amongst betaherpesvirus gH proteins. Also, we noted in this region a number of aromatic residues with periodic distribution. Tyrosine at position 48 was interesting in this regard and was common to HHV-6 A and B strain gH sequences. In order to determine the role of the FNFY motif in gH\gL association, the 12 base pairs encoding these amino acids were deleted in-frame from the epitope-tagged gH nucleotide sequence generating mutant gH11. Mutant gH12 was designed to include the minimal region needed for gL interaction (gH10) and in addition was deleted for the FNFY residues.
MAb recognition of gH requires the C-terminal fusionassociated domain with the conserved NGSV motif
The anti-gH MAbs used in this study were generated by immunization of infected cell lysates (Balachandran et al., 1989 ;  BEIH R. A. Anderson and U. A. Gompels R. A. Anderson and U. A. Gompels Fig. 2 . Reactivity of HHV-6 gH MAbs to epitope-tagged gH and gH mutants in the absence or presence of HHV-6 gL. Vero cells were infected with recombinant vaccinia virus expressing T7 RNA polymerase and then transfected with plasmid vectors encoding HHV-6 epitope-tagged gH and gH mutants in the absence or presence of gL. Proteins were radiolabelled with [ 35 S]methionine. The profile of total radiolabelled proteins was resolved in lane 2 (a-c). Equivalent aliquots of lysate containing standardized amounts of radiolabelled proteins were used in immunoprecipitations. Immunoprecipitations were carried out using lysates from cells transfected with (a) pH6H4 (gH4), (b) pH6H7 (gH7), (c) pH6H8 (gH8), (d) pH6H4 and pH6CH2 (gH4 and gL), (e) pH6H7 and pH6CH2 (gH7 and gL), (f) pH6H8 and pH6CH2 (gH8 and gL) and MAbs LP14, 2E4, 5E7, 1D3, 7A2 and 12CA5 in (a) to (c) lanes 3, 4, 5, 6, 7 and 8, respectively, or MAbs LP14, 2E4, 5E7, 1D3, and 7A2 in (d) to (f) lanes 1, 2, 3, 4 and 5, respectively. Lane 1 in panels (a) to (c) contains 14 C-labelled molecular mass markers with masses indicated in kDa. The marker positions are indicated by lines in panels (d) to (f). The arrows indicate the positions of HHV-6 glycoproteins.
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On: Thu, 20 Dec 2018 20:32:00 HHV-6 gH/gL and fusion conformation HHV-6 gH/gL and fusion conformation Foa-Tomasi et al., 1991 b ; . The target for MAbs 2E4, 5E7 and 1D3 was identified as gH by immunoprecipitation of recombinant protein . Initial experiments with a reconstituted freeze-dried hybridoma preparation of MAb 7A2 suggested that this MAb was unable to recognize gH . However, competition experiments inferred that MAb 7A2 was against gH (Qian et al., 1993) and immunoprecipitation data presented here using non-lyophilized ascites directly show 7A2 reactivity against gH (Fig. 2 a, lane 7) . The HHV-6 gH MAbs react against conformational epitopes which do not need the presence of gL for epitope formation. These MAbs have different properties in assays that measure membrane fusion. MAbs 2E4, 1D3 and 5E7 neutralized virus infectivity (as assayed by preventing cell to cell spread by cell fusion), 5E7 was least efficient, while 7A2 had no effect. Both MAbs 2E4 and 1D3 also prevented polykaryocyte formation, 2E4 more efficiently. Therefore, 2E4, 5E7 and 1D3 can be described as anti-fusion MAbs. Our study used these MAbs in combination with multiple alignment, deletion and site-directed mutagenesis to map parts of gH which are associated with membrane fusion.
Mutants gH4, gH5, gH6, gH7 and gH8 have previously been shown to be competent for interaction with gL (Anderson et al., 1996) , but possible direct or indirect roles in cell fusion (as assayed by reactivity to anti-fusion antibodies) have not been fully evaluated. Thus, the gH mutants were transiently expressed and assessed for reactivity to MAbs 2E4, 5E7, 1D3 and 7A2. Immunoprecipitations were controlled using lysates with equivalent TCA counts, as well as MAb LP14 (tagging antibody) and 12CA5, which were used as positive and negative controls, respectively, as described previously (Anderson et al., 1996) . All anti-gH MAbs immunoprecipitated epitope-tagged gH (gH4 ; Fig. 2 a, lanes 4-7) although with reproducible affinity differences such that MAbs 5E7 and 1D3 showed greater reactivity than 2E4 and 7A2 (compare lanes 5 and 6 with 4 and 7 in Fig. 2 a) . Mutant gH7 was immunoprecipitated with the tagging MAb (Fig. 2 b, lane 3) but deletion of the conserved gH C-terminal region abrogated reactivity to MAbs 2E4, 5E7, 1D3 and 7A2 (Fig. 2 b, lanes 4-7) . Interestingly, deletion of the 4 amino acid NGSV motif in mutant gH8 eliminated binding by MAbs 5E7 and 1D3 (Fig.  2 c, lanes 5 and 6) . These two MAbs showed the strongest reactivity against full-length gH (compare lanes 5 and 6 in Fig.  2 a and c) . The absence of the NGSV motif did not affect 2E4 or 7A2 reactivity (Fig. 2 c, lanes 4 and 7) . These experiments showed that components affecting the anti-fusion MAb epitopes were located in the C-terminal part of HHV-6 gH, consistent with our earlier data .
C-terminal motif mutagenesis disrupts the fusionassociated domain and gL binding at the N terminus restores this conformation
To determine whether glycosylation or conformation was important for 5E7 and 1D3 reactivity, co-expression experi-ments with the gH mutants and gL were carried out. If glycosylation at NGSV was the crucial factor then gL would be unable to rescue MAb binding since the motif had been removed, whereas gL might restore MAb reactivity if the determinant was conformational. The control tagging MAb LP14 immunoprecipitated high levels of gH (strongest affinity) and co-immunoprecipitated gL showing that the gH\gL complex was present (Fig. 2) . As expected, co-expression with gL did not alter the pattern of MAb binding to the wild-type epitope-tagged gH4 (Fig. 2 a, d) . In contrast, gH deletion to D433 (gH7) has lost recognition by these MAbs and gL coexpression has no effect ( Fig. 2 b, e) ; whereas, co-expression of gL with the NGSV deletion mutant (gH8) restored 5E7 and 1D3 reactivity as well as their differing relative affinities (Fig.  2 f, lanes 3 and 4) . Similar results restoring MAb reactivity were found for co-expression of gL with gH5, D645, which also lacks the NGSV motif which is within the 22 amino acid region deleted in this mutant (not shown). These results define sequences affecting the conformational epitopes important for the fusion-associated domain between D433 and Q667, and show that amino acids NGSV within this region do not comprise the epitope but instead contribute to a conformation recognized by two MAbs that can be induced by gL interaction.
N-terminal motif mutagenesis presents fusionassociated epitopes in immature glycoproteins
As gL binding to the N-terminal domain was required for C-terminal fusion conformation, the function of the N-terminal domain was further investigated. Mutant gH11 was tested for interaction with gL using the transient expression system described above and in our previous reports defining gH\gL complex formation and the gL binding domain (Anderson et al., 1996 ; Liu et al., 1993 a, b) . As controls, full-length epitopetagged gH was expressed alone (Fig. 3 , lane 2) or in combination with gL (data not shown) and gL expressed alone (Fig. 3, lane 3) . Immunoprecipitations were performed with the tagging MAb LP14. These experiments confirmed the specificity of MAb LP14 for epitope-tagged gH (gH4) and earlier results which showed that the HHV-6 gH\gL complex immunoprecipitated from infected cell lysates was reproduced by co-expression of these proteins in vitro (data not shown). When mutant gH11 was expressed alone or together with gL, MAb LP14 immunoprecipitated a processed form of gH and less extensively modified species comparable to immunoprecipitations with epitope-tagged gH (gH4) (Fig. 3, lanes 2, 4  and 5) . Deletion of the FNFY motif in the context of the whole glycoprotein (gH11) did not prevent gL interaction (Fig. 2,  lane 5) .
This observation raised the possibility that a requirement for the FNFY motif was masked in the context of the fulllength protein. To examine this a truncated form of gH (gH10) containing the gL binding domain and mutant gH12 which was based on gH10 and deleted for the FNFY residues were BEIJ R. A. Anderson and U. A. Gompels R. A. Anderson and U. A. Gompels tested for gL co-immunoprecipitation. Both truncated forms of gH (gH10 and gH12) were immunoprecipitated as multiple differentially processed protein species (Fig. 3, lanes 6-8) . In co-transfected cell lysates, gL was co-immunoprecipitated with gH10 (Fig. 3, lane 7) , reproducing our earlier observation, and also with gH12 (Fig. 1, lane 8) . Therefore, like epitope-tagged gH, mutant gH12 retained the ability to associate with gL using this assay.
Together, these results imply that the FNFY motif was not required for mediating protein-protein interactions between gH and gL. Whilst there are individual conserved amino acids in the gL interaction region, the FNF residues comprise the only motif of conserved residues in this divergent subfamily specific region. Similar analysis highlighted the NGS\TV motif in the conserved domain and functional importance has been inferred and tested. Therefore, the observation of gL binding by the FNFY deletion mutants shows that the major conserved motif here does not play a role in gL binding but may determine other properties.
Mutant gH11 was expressed alone or together with gL and tested for MAb reactivity using aliquots of standardized cell lysates. MAb LP14 recognizes the exogenous linear tagging epitope (at the N terminus), whereas the anti-gH MAbs recognize conformational epitopes in the C-terminal fusionassociated domain as described above. MAb LP14 immunoprecipitated mostly the mature form of the gH11 protein ( lanes 3 and 4) . Proteins were radiolabelled with [ 35 S]methionine and then immunoprecipitated with LP14 (lanes 2-5). Duplicate aliquots were either untreated (lanes 2 and 3) or digested with Endo H at 37 mC for 18 h (lanes 4 and 5). Products were resolved on a 4-20 % gradient polyacrylamide gel. Lane 1 contains 14 C-labelled molecular mass markers with masses indicated in kDa.
4, lane 3).
In contrast, the mature form of gH11 was much reduced to near background levels in immunoprecipitations with the conformation-dependent MAbs (Fig. 4, lanes 4-7) . Instead, primarily the immature, precursor forms of the gH11 protein products were detected as compared to primarily the mature form immunoprecipitated by the tagging antibody, LP14. These experiments with gH11 suggested that deletion of four amino acids in the betaherpesvirus-specific domain affected gH conformation or altered protein transport. Coexpression of mutant gH11 and gL did not change the profile of gH species immunoprecipitated with the MAbs (Fig. 4, lanes  3-6) . Therefore, the effect of deleting the four residue motif FNFY could not be reversed in the presence of gL. This is in contrast to that observed above with the NGSV deletion mutant.
Endo H sensitivity experiments were performed in order to investigate whether the FNFY deletion had altered epitope recognition due to altered glycosylation or cellular targeting, rather than altered conformation. The full-length tagged gH (gH4) and the FNFY deletion (gH11) were incubated in the presence or absence of Endo H. The results showed that both gH4 and the mutant gH11 were equally sensitive to Endo H digestion and thus have limited complex sugar modifications (Fig. 5) . Similar results were demonstrated in reactions with MAb 5E7 and in the presence of gL (not shown). Thus, there was no evidence that processing was changed for gH11. This is also supported by the immunoprecipitation results of gH11 using the tagging antibody, LP14, which recognizes the linear epitope inserted at the N terminus of gH11. LP14, unlike the conformation-specific antibodies, clearly immunoprecipitated mature gH indistinguishable from the wild-type tagged gH4 (Figs 3, 4 and 5) . Thus, these data support conformational changes during maturation affecting the epitope in the fusionassociated region.
Discussion
This study shows effects on fusion-associated epitopes between the N-and C-terminal extracellular domains of gH. In the N-terminal region of gH, deletion of the amino acids FNFY in both a full-length and a truncated protein (composed of the minimal gL interaction domain) were competent for interaction with gL in a transient vaccinia virus expression system. However, the full-length FNFY mutant (gH11) had aberrant reactivity to conformation-dependent MAbs which recognize (or are affected by mutations within) the C-terminal ' fusionassociated ' domain. This domain may have a direct or indirect role in cell fusion based on the reactivities with anti-fusion antibodies. Although the tagging antibody recognized its linear epitope in mature gH, the conformational MAbs lost reactivity to mature gH and now recognized primarily immature forms. This was unaltered in the presence of gL. Results of Endo H digestion showed no difference between the mutant and wild-type, suggesting indirectly that gH11 reactivity to the conformational gH MAbs was not due to abnormal intracellular trafficking or glycosylation but instead may have been due to altered protein structure.
In our earlier mutagenesis study we showed that sequences within the external C-terminal domain were required for formation of the antigenic determinants for MAb 2E4, 5E7 and 1D3 . Here, similar analysis using mutant gH6, which encodes a gH protein with the entire external domain but lacking the membrane spanning region and cytoplasmic tail, duplicated these results and extended them to show that MAb 7A2 also immunoprecipitated the truncated glycoprotein encoded by gH6 (not shown). Furthermore, the experiments with mutant gH5 and gH7 indicate that the Cterminal extracellular part of gH is required for recognition by the panel of MAbs used here. As three of these have been shown to reduce virus infectivity by inhibition of membrane fusion it can be extrapolated that the C-terminal region of gH is directly or indirectly important for fusion. Galdiero et al. (1997) also showed by introduction of four to five residues in linker insertion mutagenesis that sites in the conserved Cterminal third of HSV-1 gH are important for cell fusion and virus entry. Additionally, the arginine at position 389 of the HHV-6 B strain HST has been shown to be important in the formation of the strain-specific OHV3 neutralizing epitope (Takeda et al., 1997) . Since mutant gH7 retains the corresponding lysine residue at this position in HHV-6 strain U1102 it is possible that this contributes to the epitope of the strain A gH MAbs used here.
We hypothesized that the conserved nature of the NGSV motif in this region may indicate a conserved function in fusion. However, deletion of the amino acids NGSV (mutant gH8) did not abolish 2E4 and 7A2 reactivity and MAbs 5E7 Reactivity was determined by interaction with conformation-dependent neutralizing and syncytia-inhibiting MAbs. All mutants are derivatives of gH4, the tagged wt ; thus, all constructs are N-terminally epitope-tagged. This is a positive control for all reactions as the tagging MAb, LP14, recognizes all mature mutant gH forms. gH4 includes all 694 amino acids of wild-type gH ; gH6 includes amino acids 1-667 ; gH5 includes gH amino acids 1-645 ; gH8 is deleted for gH residues 652-645 inclusive (i.e. ∆NGSV) ; gH11 is deleted for gH residues 45-48 inclusive (i.e. ∆FNFY) ; gH7 includes gH amino acids 1-433. Numbers are based on the wild-type gH amino acid sequence. gH5 and gH8 results are shown for 5E7 and 1D3 MAbs. and 1D3 recognized gH8 when co-expressed with gL. Therefore, N-linked glycosylation at this site is not important for epitope formation or protein function. Moreover, it is unlikely that NGSV is part of the epitope for 5E7 or 1D3. Given the reactivity of the deletion mutant in the presence of gL, it is more likely that NGSV affects formation of a conformation important for infection and fusogenic cellular spread. This is consistent with experiments in which a recombinant HSV-1 virus, mutated at the homologous motif to disrupt the N-glycosylation consensus site, retained in vitro growth properties comparable to wild-type virus (Galdiero et al., 1997) . Since the lack of the NGSV motif can be compensated for by gL co-expression with gH8, this suggests that a function of these residues is to facilitate a gH conformation recognized by the 5E7 and ID3 MAbs which in the absence of the motif can be induced by association with gL.
We have previously shown that gL interacts with an Nterminal domain (Anderson et al., 1996) . Therefore, gL interaction with the N-terminal part of gH has an effect in a disparate part of the gH protein. This could be a long distance effect of gL on gH structure or the tertiary structure of gH may be such that the interaction and fusion-associated domains are in close proximity. MAb 5E7 and 1D3 are distinct from the HSV-1 LP11 MAb because these HHV-6 MAbs react with gH in the absence of gL whereas LP11 has been shown to recognize a gL-dependent Nterminal conformational epitope (Gompels et al., 1991 ; Gompels & Minson, 1989) . However, 5E7 and 1D3 reactivity on the NGSV deletion mutant (gH8) are similar in that they now recognize a gL-dependent conformational epitope. The difference in this study is that it links gL binding at the Nterminus to folding affected by the conserved C-terminal fusion-associated domain. Thus, this indicates the interaction of gL with gH is not a passive process involved only in cellular and virion targeting.
In summary, this is the first indication for potential interactions between the N-and C-terminal extracellular domains of gH. These results are collated in Table 1 . The specific mutagenesis studies targeted conserved motifs in these domains identified from our earlier deletion studies which showed evidence for N-terminal gL binding and C-terminal ' fusion-associated ' extracellular domains (Anderson et al., 1996 ; Liu et al., 1993 b) . The N-terminal mutation (gH11 ; FNFY) affected conformation of epitopes associated with the C-terminal domain and this is required for infection. This was demonstrated by reduced recognition of the mature gH in favour of the immature form by the conformation-dependent neutralizing and syncytia-inhibiting antibodies described here. However, the mature form was produced as demonstrated by reaction with antibody to a linear epitope inserted at the N terminus. The conformational difference was independent of changes in sensitivity to Endo H. Thus, in this mutant the mature form was produced in normal levels and processed, but had an altered conformation associated with sequences in the C-terminal domain such that the epitopes now primarily recognized were in the immature rather than the mature form. Addition of gL did not change these results. Conversely, the Cterminal mutation (gH8 ; NGSV deletion) resulted in loss of recognition by two of these MAbs, which was restored by coexpression with gL and its resultant binding of the N-terminal domain. In this case, the restored recognition was to the mature form of gH, thus indicating that the deleted motif itself was not part of the epitope but influenced formation of the fusionassociated domain. Thus, in one case the N-terminal mutation results in immature gH which has the C-terminal fusionassociated conformation which is reduced during processing to the mature form even in the presence of gL. Here, the Nterminal mutation in the domain where gL binds still allows gL binding but affects folding of the C-terminal associated domain. Whereas, the C-terminal mutation (extracellular) loses all recognition by two MAbs which can be returned by binding gL to the N-terminal domain. One model is that mutations at either end of gH influence binding of the MAbs which affect a conformation associated with cell fusion. Another model incorporating these observations is that gL binding at the Nterminal domain draws together both the N-and C-terminal HHV-6 gH/gL and fusion conformation HHV-6 gH/gL and fusion conformation domains in order to allow\protect or mask correct folding of the C-terminal fusion-associated domain during processing to the mature form and this is essential for infection. If gL brings over a functional N-terminal domain then this C-terminal folding is stabilized (NGSV deletion), whereas if a defective Nterminal domain is presented during processing to the mature form then the conformation is retained in the immature product (FNFY deletion).
